2026 NPPES data Interventional Pain Medicine Physician NPI 1447542469 MD
Verify on CMS →

DEV SINHA, MD

Interventional Pain Medicine Physician in CLIFTON, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
454
Medicare Part D claims · 125 beneficiaries · Interventional Pain Medicine Physician avg: 2K
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$1.4K
38 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DEV SINHA, MD reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 454 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
454
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEV SINHA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

DEV SINHA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DEV SINHA, MD?

Below national average

NPI registry status

Active

Issued 05/10/2011

NPI 1447542469

Primary specialty

Interventional Pain Medicine Physician

Niche

1,528 US NPIs in this specialty

Medicare Part D claims

454 79% vs specialty avg

2023 prescription claims

Specialty avg: 2,197

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in New Jersey

How Interventional Pain Medicine Physician compares to other specialties among New Jersey providers

New Jersey providers

Interventional Pain Medicine Physician share within New Jersey

1. Interventional Pain Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Interventional Pain Medicine Physician share within New Jersey

Medicare quality performance — MIPS

DEV SINHA, MD's 2023 MIPS final score plotted against the Interventional Pain Medicine Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Interventional Pain Medicine Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Interventional Pain Medicine Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEV SINHA, MD is a Interventional Pain Medicine Physician provider practicing in CLIFTON, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1447542469. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DEV SINHA, MD appears in the CMS NPPES registry as a Interventional Pain Medicine Physician provider holding MD credentials at 1117 ROUTE 46, CLIFTON, NJ, 07013, with a listed phone of (973) 777-5444. NPI 1447542469 was issued on 05/10/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SINHA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 454 prescription claims written by this provider, covering 125 Medicare beneficiaries and totaling roughly $40K in drug spend, split 10% brand-name and 90% generic by claim count, with an opioid prescribing rate of 53.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Interventional Pain Medicine Physician is a narrow specialty nationwide, with 1,528 enrolled providers across 53 states and an average of 2,197 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1117 ROUTE 46
CLIFTON, NJ 07013

Provider Details

NPI 1447542469
Specialty Interventional Pain Medicine Physician
Credentials MD
Gender Male
NPI Issued 05/10/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Hospital and facility affiliations

Facilities where DEV SINHA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GARDEN STATE PAIN CONTROL CENTER PA
CLIFTON, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEV SINHA, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.4K

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

DEV SINHA, MD — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 454 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

454
Total Claims
$40K
Total Drug Cost
125
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
462
Total Day Supply
12,080
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$31K
Generic Drug Cost
$9K
Opioid Claims
241 (53.1% rate)

Patient Demographics

Average Patient Age
64.8 years
Avg HCC Risk Score
1.24
Gender Split
69% female / 31% male
Age Distribution
<65: 52, 65-74: 44, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
69
Oxycodone Hcl
54
Gabapentin
38
Cyclobenzaprine Hcl
37
Tramadol Hcl
35
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
23
Oxycontin
Oxycodone Hcl
21
Meloxicam
16
Pregabalin
14
Tizanidine Hcl
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Interventional Pain Medicine Physician Overview

How DEV SINHA, MD fits within the Interventional Pain Medicine Physician landscape nationally.

1,528
Interventional Pain Medicine Physician Providers in US
53
States with Interventional Pain Medicine Physician
2,197
Avg Claims per Provider

DEV SINHA, MD's 454 claims are below the specialty average of 2,197.

Nearby Interventional Pain Medicine Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as SINHA.

Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEV SINHA, MD's specialty?
DEV SINHA, MD specializes in Interventional Pain Medicine Physician and practices in CLIFTON, New Jersey. Credentials: MD.
How much does DEV SINHA, MD prescribe under Medicare Part D?
In 2023, DEV SINHA, MD wrote 454 Medicare Part D claims totaling $40K in drug costs for 125 beneficiaries.
What is DEV SINHA, MD's Medicare quality score?
DEV SINHA, MD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DEV SINHA, MD located?
DEV SINHA, MD is located at 1117 ROUTE 46, CLIFTON, NJ, 07013. Phone: (973) 777-5444.
What is DEV SINHA, MD's NPI number?
DEV SINHA, MD's National Provider Identifier (NPI) is 1447542469, issued on 05/10/2011.
Does DEV SINHA, MD prescribe more brand-name or generic drugs?
DEV SINHA, MD's prescribing is 10% brand-name and 90% generic drugs by claim count, with $31K in brand drug costs.
Does DEV SINHA, MD prescribe opioids?
Yes, DEV SINHA, MD had 241 opioid claims in 2023 with an opioid prescribing rate of 53.1%.
How many Interventional Pain Medicine Physician providers are there in the US?
There are 1,528 Interventional Pain Medicine Physician providers across 53 states in the US. The average Interventional Pain Medicine Physician provider writes 2,197 Medicare Part D claims per year.
What drugs does DEV SINHA, MD prescribe most often?
Based on 2023 Medicare Part D data, DEV SINHA, MD's most frequently prescribed drugs include Oxycodone-Acetaminophen, Oxycodone Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEV SINHA, MD accept Medicare?
DEV SINHA, MD appears in CMS Medicare data with 454 Part D claims and 125 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEV SINHA, MD's credentials?
DEV SINHA, MD's NPI is 1447542469 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology